FABP4 and metabolic syndrome: In fact, elevated serum concentrations of FABP4 are known to be associated with obesity [28], insulin resistance [29], hypertension (HT) [30], dyslipidemia [31], atherosclerosis [32], renal dysfunction [33], purine metabolism [34], heart failure and cardiovascular events [35].